These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31391392)
21. Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy. Nantel S; Parboosingh J; Poon MC Med Pediatr Oncol; 1990; 18(2):143-5. PubMed ID: 1689451 [TBL] [Abstract][Full Text] [Related]
22. The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma. Avigdor A; Sirotkin T; Kedmi M; Ribakovsy E; Berkowicz M; Davidovitz Y; Kneller A; Merkel D; Volchek Y; Davidson T; Goshen E; Apter S; Shimoni A; Ben-Bassat I; Nagler A Ann Hematol; 2014 Aug; 93(8):1297-304. PubMed ID: 24595734 [TBL] [Abstract][Full Text] [Related]
23. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study. Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700 [TBL] [Abstract][Full Text] [Related]
24. Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma. Lee GW; Go SI; Kim SH; Hong J; Kim YR; Oh S; Kim SY; Do YR; Lee H; Lee SI; Bae SH; Oh SY; Song MK; Lee WS; Lee B; Kim JS; Kim MK; Kang HJ; Ahn JS; Yhim HY; Kim HJ; Kim SJ; Kim WS; Suh C; Leuk Lymphoma; 2015 Apr; 56(4):1020-6. PubMed ID: 25039351 [TBL] [Abstract][Full Text] [Related]
25. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753 [TBL] [Abstract][Full Text] [Related]
26. Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma. Song HN; Kim SJ; Ko YH; Kim WS Acta Haematol; 2016; 136(3):186-90. PubMed ID: 27623181 [TBL] [Abstract][Full Text] [Related]
27. Beta-HCG aberrant expression in primary mediastinal large B-cell lymphoma. Fraternali-Orcioni G; Falini B; Quaini F; Campo E; Piccioli M; Gamberi B; Pasquinelli G; Poggi S; Ascani S; Sabattini E; Pileri SA Am J Surg Pathol; 1999 Jun; 23(6):717-21. PubMed ID: 10366155 [TBL] [Abstract][Full Text] [Related]
28. Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma. Avilés A; Neri N; Fernández R; Huerta-Guzmán J; Nambo MJ Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1227-31. PubMed ID: 22172907 [TBL] [Abstract][Full Text] [Related]
29. Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena Cava. Nakamura S; Kagawa K; Sumitani R; Uemura M; Takahashi M; Iwasa M; Fujii S; Miki H; Abe M Intern Med; 2017; 56(15):2043-2047. PubMed ID: 28768978 [TBL] [Abstract][Full Text] [Related]
30. Primary mediastinal large B-cell lymphoma. Ergul SM; Lal A; Afri L; Frei-Lahr D South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098 [TBL] [Abstract][Full Text] [Related]
31. Large B cell lymphoma with cardiac infiltration. Koehler F; Borges AC; Fotuhi PC Heart; 2003 Nov; 89(11):1282. PubMed ID: 14594875 [No Abstract] [Full Text] [Related]
32. Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy. Xu LM; Fang H; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Ren H; Zhou LQ; Li YX Leuk Lymphoma; 2013 Aug; 54(8):1684-90. PubMed ID: 23137070 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of primary mediastinal large B-cell lymphomas]. Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753 [TBL] [Abstract][Full Text] [Related]
34. [Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas]. Schneider T; Tóth E; Lovey J; Molnár Z; Deák B; Várady E; Csomor J; Matolcsy A; Lengyel Z; Petri K; Gaudi I; Rosta A Orv Hetil; 2011 May; 152(19):735-42. PubMed ID: 21498163 [TBL] [Abstract][Full Text] [Related]
37. Rituximab plus CHOP for diffuse large-B-cell lymphoma. Akhtar S; Maghfoor I N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349 [No Abstract] [Full Text] [Related]
38. Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma. Kayamori K; Shono K; Onoda M; Yokota A Hematology; 2019 Dec; 24(1):52-59. PubMed ID: 30101679 [TBL] [Abstract][Full Text] [Related]
39. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases]. Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196 [TBL] [Abstract][Full Text] [Related]
40. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study. Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]